Hong Kong Stock Movement: IVD MEDICAL surged 17.12%, with active capital inflow attracting market attention

Hong Kong Stock Movement IVD MEDICAL, up 17.12%, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Stocks Ranked High in Industry Transaction Volume Baiyunshan, up 0.22%. Based on recent news, On December 28, Baiyunshan Biotech received the drug registration certificate for the freeze-dried human rabies vaccine (Vero cells) approved by the National Medical Products Administration. This move will further enrich the company's product structure and enhance its competitiveness in the vaccine market. On December 27, Guangzhou Pharmaceutical Group announced that it will complete R&D investments of 10 billion to 15 billion yuan during the 14th Five-Year Plan period and further promote innovation transformation through mergers and acquisitions and industrial investments. This move demonstrates the company's long-term strategy in the innovative drug sector. On December 26, Baiyunshan announced that its subsidiary Baiyunshan Biotech officially received the drug registration certificate for the freeze-dried human rabies vaccine (Vero cells) approved by the National Medical Products Administration. This news further enhances market confidence in the company. The trend of innovation transformation in the pharmaceutical industry is evident, with increased capital inflow. China National Pharmaceutical Group, down 0.15%, with a transaction volume of HKD 25.88 million, and no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. YaoShibang, up 0.35%, with a transaction volume of HKD 20.77 million, and no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Stocks Ranked High in Industry Market Capitalization Shanghai Pharmaceuticals, up 0.36%, with a market capitalization of HKD 43.2 billion, and no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation